Skip to main
IVVD

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc has positioned itself favorably within the competitive biopharmaceutical landscape by receiving FDA emergency use authorization for its lead product, PEMGARDA, which addresses the critical need for COVID-19 prevention in immunocompromised individuals. The company's upcoming Phase 3 program, REVOLUTION, aims to evaluate VYD2311, potentially enhancing its market presence significantly, especially if its efficacy is demonstrated against mRNA vaccines within a larger patient population. This strategic focus on innovative monoclonal antibody therapies, including ongoing developments for RSV and other viral diseases, contributes to a strong outlook, bolstered by the substantial revenue potential of the current COVID-19 vaccine market.

Bears say

Invivyd Inc. faces significant challenges as its lead product, PEMGARDA, demonstrated a markedly diminished effectiveness against the omicron variant, with activity dropping by approximately 200-fold, indicating a potential reduction in market viability. Additionally, the concerning trend of decreasing vaccination rates for COVID-19 and influenza undermines the commercial potential for Invivyd's therapies, especially as protective levels from mRNA vaccines wane drastically among vulnerable populations such as the elderly and immunocompromised. Overall, the combination of these factors suggests a constricting market opportunity for Invivyd's monoclonal antibody therapies.

Invivyd Inc (IVVD) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Mar 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.